Naurex's Grant

Naurex raised a round of funding on January 24, 2009. Investors include Qualifying Therapeutic Discovery Project.

Naurex is a biopharmaceutical company developing novel modulators of the NMDA receptor to treat challenging diseases of the central nervous system (CNS). The company's first-generation compound, GLYX-…

Articles about Naurex's Grant: